TY - JOUR
T1 - Transcriptional regulatory network controlling the ontogeny of hematopoietic stem cells
AU - Gao, Peng
AU - Chen, Changya
AU - Howell, Elizabeth D.
AU - Li, Yan
AU - Tober, Joanna
AU - Uzun, Yasin
AU - He, Bing
AU - Gao, Long
AU - Zhu, Qin
AU - Siekmann, Arndt F.
AU - Speck, Nancy A.
AU - Tan, Kai
N1 - Funding Information:
We thank the Research Information Services at the Children’s Hospital of Philadelphia for providing computing support, and Andrea Stout and Jasmine Zhao at the University of Pennsylvania Cell and Developmental Biology Microscopy Core facility for microscopy assistance. This work was supported by National Institutes of Health grants GM104369, GM108716, HG006130 (to K.T.), HL091724 (to N.A.S.), HD089245 (to K.T. and N.A.S.), and HD083185 (E.D.H.).
Publisher Copyright:
© 2020 Gao et al.
PY - 2020/7
Y1 - 2020/7
N2 - Hematopoietic stem cell (HSC) ontogeny is accompanied by dynamic changes in gene regulatory networks. We performed RNA-seq and histone mark ChIP-seq to define the transcriptomes and epigenomes of cells representing key developmental stages of HSC ontogeny in mice. The five populations analyzed were embryonic day 10.5 (E10.5) endothelium and hemogenic endothelium fromthe major arteries, an enriched population of prehematopoietic stem cells (pre-HSCs), fetal liver HSCs, and adult bone marrow HSCs. Using epigenetic signatures, we identified enhancers for each developmental stage. Only 12% of enhancers are primed, and 78% are active, suggesting the vast majority of enhancers are established de novo without prior priming in earlier stages. We constructed developmental stage-specific transcriptional regulatory networks by linking enhancers and predicted bound transcription factors to their target promoters using a novel computational algorithm, target inference via physical connection (TIPC). TIPC predicted known transcriptional regulators for the endothelial-to-hematopoietic transition, validating our overall approach, and identified putative novel transcription factors, including the broadly expressed transcription factors SP3 and MAZ. Finally, we validated a role for SP3 and MAZ in the formation of hemogenic endothelium. Our data and computational analyses provide a useful resource for uncovering regulators of HSC formation.
AB - Hematopoietic stem cell (HSC) ontogeny is accompanied by dynamic changes in gene regulatory networks. We performed RNA-seq and histone mark ChIP-seq to define the transcriptomes and epigenomes of cells representing key developmental stages of HSC ontogeny in mice. The five populations analyzed were embryonic day 10.5 (E10.5) endothelium and hemogenic endothelium fromthe major arteries, an enriched population of prehematopoietic stem cells (pre-HSCs), fetal liver HSCs, and adult bone marrow HSCs. Using epigenetic signatures, we identified enhancers for each developmental stage. Only 12% of enhancers are primed, and 78% are active, suggesting the vast majority of enhancers are established de novo without prior priming in earlier stages. We constructed developmental stage-specific transcriptional regulatory networks by linking enhancers and predicted bound transcription factors to their target promoters using a novel computational algorithm, target inference via physical connection (TIPC). TIPC predicted known transcriptional regulators for the endothelial-to-hematopoietic transition, validating our overall approach, and identified putative novel transcription factors, including the broadly expressed transcription factors SP3 and MAZ. Finally, we validated a role for SP3 and MAZ in the formation of hemogenic endothelium. Our data and computational analyses provide a useful resource for uncovering regulators of HSC formation.
UR - http://www.scopus.com/inward/record.url?scp=85087530454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087530454&partnerID=8YFLogxK
U2 - 10.1101/GAD.338202.120
DO - 10.1101/GAD.338202.120
M3 - Article
C2 - 32499402
AN - SCOPUS:85087530454
SN - 0890-9369
VL - 34
JO - Genes and Development
JF - Genes and Development
IS - 13-14
ER -